Fasenra (benralizumab) is a biologic drug therapy that is an add-on maintenance treatment for patients 12 years and older with severe eosinophilic asthma.
Fasenra has been proven to reduce eosinophil levels in the blood, which helps prevent asthma attacks, improves breathing and lung function, and better controls asthma symptoms. Taking Fasenra may reduce or completely eliminate a patient’s need to take oral steroids daily.
Fasenra is administered via injection. The first 3 doses are administered once every 4 weeks, and then once every 8 weeks thereafter.
Click here to visit the pharmaceutical website for Fasenra.
This product may be used to treat other conditions, not listed here. If you are currently using or have a physician’s order to begin using this product for an unlisted condition and you have questions related to whether or not we can offer you infusion services, please call our office or fill out a form and a member of our team will reach out to you as soon as possible.